Blood Marker Soluble PD-1 Flags Cancer Return After Liver Transplant in Immunotherapy Patients
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and...
Genomic Test May Reveal Which Prostate Cancer Patients Gain Most From Hormone Therapy
An NRG Oncology SPPORT trial analysis found that Luminal B prostate tumors identified by the PAM50 genomic classifier predicted a...
Neglected respiratory viruses rival influenza and RSV in blood cancer patients
For adults undergoing treatment for cancers of the blood and immune system, a viral infection of the lower respiratory tract...
Universal Psychosocial Screening Becomes Standard of Care in Pediatric Cancer
A two-year implementation study at a major children's cancer center shows that universal psychosocial screening across the pediatric cancer treatment...
Scientists Link a DNA-Building Enzyme to Fat Rewiring and Chemotherapy Failure in Pancreatic Cancer
A new study identifies RRM2 as a gene that connects nucleotide metabolism and SREBP1/FASN-driven lipid remodeling to gemcitabine resistance in...
Hidden Gene Variants May Explain Why Chemotherapy Hits Some Patients Harder Than Others
A new review links inherited variants in ABCB1, ABCC1, and ABCG2 drug transporter genes to differences in chemotherapy and targeted...
Nose and Blood Tell Different Recovery Stories in Allergy Immunotherapy Study
Paired metabolomic profiling of nasal secretions and plasma reveals that allergic rhinitis and its recovery during subcutaneous immunotherapy unfold through...
Korean Cancer Survivors Get a Validated Tool to Voice Their Care Priorities
A multicenter Korean study has validated a 34-item Korean version of the Patient-Centered Survivorship Care Index, giving cancer survivors in...
Postoperative ctDNA May Predict Recurrence Risk in HPV-Negative Head and Neck Cancer
A new meta-analysis of eight studies suggests that detectable postoperative circulating tumor DNA is associated with a ten-fold elevated recurrence...
Five-Week Radiation Course Matches Seven-Week Standard After Prostate Cancer Surgery, Trial Finds
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule achieved biochemical control and...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!